Recombinant Human-Granulocyte Colony Stimulating Factor (GCSF); filgrastim 300 µg
Available as a pre-filled syringe
Mechanism of Action:
Filgrastim (produced in E. coli) is a non-glycosylated recombinant G-CSF used to stimulate the bone marrow to produce granulocytes and stem cells. G-CSF then stimulates the bone marrow to release them into the blood. It also stimulates the survival, proliferation, differentiation, and function of neutrophil precursors and mature neutrophils.
Cancer patients receiving myelosuppressive chemotherapy; patients with acute myeloid leukemia receiving induction or consolidation chemotherapy; cancer patients receiving bone-marrow transplant (BMT); patients with severe chronic neutropenia; peripheral blood progenitor cell (PBPC) collection and therapy in cancer patients
NUFIL SF™ is contraindicated in patients with known hypersensitivity to E coli-derived proteins, Filgrastim, or any component of the product.